关注
Jamie Anastas
Jamie Anastas
在 bcm.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
WNT signalling pathways as therapeutic targets in cancer
JN Anastas, RT Moon
Nature Reviews Cancer 13 (1), 11-26, 2013
21712013
Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation
GR Willis, A Fernandez-Gonzalez, J Anastas, SH Vitali, X Liu, M Ericsson, ...
American journal of respiratory and critical care medicine 197 (1), 104-116, 2018
5402018
WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors
JN Anastas, RM Kulikauskas, T Tamir, H Rizos, GV Long, EM Von Euw, ...
The Journal of clinical investigation 124 (7), 2877-2890, 2014
2172014
New regulators of Wnt/β-catenin signaling revealed by integrative molecular screening
MB Major, BS Roberts, JD Berndt, S Marine, J Anastas, N Chung, ...
Science signaling 1 (45), ra12-ra12, 2008
1682008
A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression
JN Anastas, TL Biechele, M Robitaille, J Muster, KH Allison, S Angers, ...
Oncogene 31 (32), 3696-3708, 2012
1452012
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG
JN Anastas, BM Zee, JH Kalin, M Kim, R Guo, S Alexandrescu, MA Blanco, ...
Cancer cell 36 (5), 528-544. e10, 2019
1422019
Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling
JD Berndt, A Aoyagi, P Yang, JN Anastas, L Tang, RT Moon
Journal of Cell Biology 194 (5), 737-750, 2011
1152011
Histone lysine demethylase inhibitors
A Jambhekar, JN Anastas, Y Shi
Cold Spring Harbor perspectives in medicine 7 (1), a026484, 2017
712017
WLS inhibits melanoma cell proliferation through the β‐catenin signalling pathway and induces spontaneous metastasis
PT Yang, JN Anastas, RA Toroni, MM Shinohara, JM Goodson, ...
EMBO molecular medicine 4 (12), 1294-1307, 2012
372012
BAF complex maintains glioma stem cells in pediatric H3K27M glioma
E Panditharatna, JG Marques, T Wang, MC Trissal, I Liu, L Jiang, A Beck, ...
Cancer discovery 12 (12), 2880-2905, 2022
272022
Functional crosstalk between WNT signaling and tyrosine kinase signaling in cancer
JN Anastas
Seminars in oncology 42 (6), 820-831, 2015
262015
RACK7 recognizes H3. 3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma
F Jiao, Z Li, C He, W Xu, G Yang, T Liu, H Shen, J Cai, JN Anastas, Y Mao, ...
Science Advances 6 (29), eaba2113, 2020
242020
Histone serotonylation: can the brain have “happy” chromatin?
JN Anastas, Y Shi
Molecular cell 74 (3), 418-420, 2019
212019
Mesenchymal stromal cell therapy for respiratory complications of extreme prematurity
B Thébaud
American Journal of Perinatology 35 (06), 566-569, 2018
112018
A road map for the treatment of pediatric diffuse midline glioma
C Koschmann, WN Al-Holou, MM Alonso, J Anastas, P Bandopadhayay, ...
Cancer cell 42 (1), 1-5, 2024
42024
Applying single cell multi-omic analyses to understand treatment resistance in pediatric high grade glioma
RL Murdaugh, JN Anastas
Frontiers in Pharmacology 14, 1002296, 2023
12023
Wnt Signaling in Melanoma
JN Anastas, AJ Chien
Wnt Signaling in Development and Disease: Molecular Mechanisms and …, 2014
12014
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
L Zhang, JI Hsu, ED Braekeleer, CW Chen, TD Patel, AG Martell, ...
eLife 12, RP91611, 2024
2024
IMMU-18. ENHANCING GD2. CAR T CELL THERAPY FOR DIFFUSE MIDLINE GLIOMA WITH LSD1 AND HDAC INHIBITORS
RL Murdaugh, M Shekar, BR Eberl, JR Tremblay, RU Richard, L Nguyen, ...
Neuro-Oncology 26 (Suppl 4), 0, 2024
2024
MODL-12. REPURPOSING SSRI/SNRI TARGETING NEUROTRANSMITTER SIGNALING TO SENSITIZE DMG TO CDK9 INHIBITORS
RL Murdaugh, BR Eberl, RU Richard, JR Tremblay, A Dei-Ampeh, ...
Neuro-Oncology 26 (Suppl 4), 0, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20